The 2023 data reveals that France leads with the highest environmentally related tax revenue, followed by the Netherlands and Poland. In terms of year-on-year changes, France saw a notable increase of 7.75%, while most other countries, such as the Netherlands and Poland, experienced declines. Notably, the UK witnessed a significant drop of over 9%. On a five-year basis, Belgium had the steepest decline, while Switzerland saw slight growth. This reflects mixed trends across European countries.
Future trends to monitor include:
- Potential policy shifts influencing environmental tax structures.
- Evolving manufacturing practices affecting pollution levels and tax implications.
- Economic factors impacting pharmaceutical and chemical manufacturing outputs.
Top countries in Environmentally Related Tax Revenue from Taxes on Pollution in Manufacturing of Chemicals, Basic Pharmaceuticals and Preparations by Country
| # | 10 Countries | Million US Dollars PPP = 2015 | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 France | 76.38 | 2023 | +6.84% | +7.75% | View data |
| 2 | 2 Netherlands | 22.26 | 2023 | +3.7% | -2.21% | View data |
| 3 | 3 Poland | 12.62 | 2023 | -2.94% | -1.71% | View data |
| 4 | 4 United Kingdom | 10.25 | 2023 | -10.76% | -9.02% | View data |
| 5 | 5 Sweden | 7.97 | 2023 | -0.94% | +0.0069% | View data |
| 6 | 6 Denmark | 6.22 | 2023 | -0.59% | -1.83% | View data |
| 7 | 7 Slovakia | 4.97 | 2023 | -6.45% | -7.89% | View data |
| 8 | 8 Czech Republic | 2.27 | 2023 | -8.79% | -6.95% | View data |
| 9 | 9 Lithuania | 1.34 | 2023 | -0.2% | -4.22% | View data |
| 10 | 10 Serbia | 1.21 | 2023 | +0.61% | +2.15% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
